Prenatal diagnosis of severe mitochondrial diseases caused by nuclear gene defects: a study in Japan.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
11 02 2021
Historique:
received: 06 11 2020
accepted: 28 12 2020
entrez: 12 2 2021
pubmed: 13 2 2021
medline: 16 11 2021
Statut: epublish

Résumé

Prenatal diagnoses of mitochondrial diseases caused by defects in nuclear DNA (nDNA) or mitochondrial DNA have been reported in several countries except for Japan. The present study aimed to clarify the status of prenatal genetic diagnosis of mitochondrial diseases caused by nDNA defects in Japan. A comprehensive genomic analysis was performed to diagnose more than 400 patients, of which, 13 families (16 cases) had requested prenatal diagnoses. Eight cases diagnosed with wild type homozygous or heterozygous variants same as either of the heterozygous parents continued the pregnancy and delivered healthy babies. Another eight cases were diagnosed with homozygous, compound heterozygous, or hemizygous variants same as the proband. Of these, seven families chose to terminate the pregnancy, while one decided to continue the pregnancy. Neonatal- or infantile-onset mitochondrial diseases show severe phenotypes and lead to lethality. Therefore, such diseases could be candidates for prenatal diagnosis with careful genetic counseling, and prenatal testing could be a viable option for families.

Identifiants

pubmed: 33574353
doi: 10.1038/s41598-021-81015-y
pii: 10.1038/s41598-021-81015-y
pmc: PMC7878886
doi:

Substances chimiques

Connexins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3531

Commentaires et corrections

Type : ErratumIn

Références

Nat Rev Genet. 2012 Dec;13(12):878-90
pubmed: 23154810
J Med Genet. 2010 Apr;47(4):257-61
pubmed: 19914907
Orphanet J Rare Dis. 2020 Jul 24;15(1):169
pubmed: 32703289
Brain Dev. 2014 Sep;36(8):730-3
pubmed: 24113355
Essays Biochem. 2018 Jul 20;62(3):399-408
pubmed: 29950319
Am J Med Genet. 2001 Spring;106(1):102-14
pubmed: 11579429
Am J Hum Genet. 1999 Aug;65(2):474-82
pubmed: 10417290
J Med Genet. 2017 Feb;54(2):73-83
pubmed: 27450679
Mol Genet Metab Rep. 2016 Aug 04;8:74-6
pubmed: 27536553
Cytogenet Genome Res. 2018;154(3):137-146
pubmed: 29656286
Nat Genet. 2003 Feb;33(2):183-6
pubmed: 12539044
J Hum Genet. 2019 Feb;64(2):113-125
pubmed: 30459337
Ultrasound Obstet Gynecol. 2016 Jan;47(1):38-44
pubmed: 26581188
J Obstet Gynaecol Can. 2015 Jul;37(7):656-668
pubmed: 26366824
Hum Mutat. 2018 Apr;39(4):461-470
pubmed: 29282788
PLoS Genet. 2016 Jan 07;12(1):e1005679
pubmed: 26741492
Prenat Diagn. 2011 Oct;31(10):1007-9
pubmed: 21732393
Brain. 2003 Aug;126(Pt 8):1905-12
pubmed: 12805096
Nat Rev Genet. 2005 May;6(5):389-402
pubmed: 15861210
Bioinformation. 2015 May 28;11(5):254-60
pubmed: 26124570
Eur J Hum Genet. 2014 Nov;22(11):1255-9
pubmed: 24642831
Biochim Biophys Acta. 2014 Apr;1840(4):1355-9
pubmed: 24462578
Neurotherapeutics. 2013 Apr;10(2):243-50
pubmed: 23264099

Auteurs

Nana Akiyama (N)

Center for Medical Genetics, Chiba Children's Hospital, Chiba, Japan.
Department of Medical Genetics/Medical Ethics, Kyoto University School of Public Health, Kyoto, Japan.

Masaru Shimura (M)

Department of Metabolism, Chiba Children's Hospital, 579-1 Heta-cho, Midori-ku, Chiba, 266-0007, Japan.

Taro Yamazaki (T)

Department of Pediatrics, Faculty of Medicine, Saitama Medical University, Saitama, Japan.

Hiroko Harashima (H)

Department of Pediatrics, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
Department of Clinical Genomics, Faculty of Medicine, Saitama Medical University, Saitama, Japan.

Takuya Fushimi (T)

Department of Metabolism, Chiba Children's Hospital, 579-1 Heta-cho, Midori-ku, Chiba, 266-0007, Japan.

Tomoko Tsuruoka (T)

Department of Neonatology, Chiba Children's Hospital, Chiba, Japan.

Tomohiro Ebihara (T)

Department of Neonatology, Chiba Children's Hospital, Chiba, Japan.

Keiko Ichimoto (K)

Department of Metabolism, Chiba Children's Hospital, 579-1 Heta-cho, Midori-ku, Chiba, 266-0007, Japan.

Ayako Matsunaga (A)

Department of Metabolism, Chiba Children's Hospital, 579-1 Heta-cho, Midori-ku, Chiba, 266-0007, Japan.

Megumi Saito-Tsuruoka (M)

Department of Clinical Genomics, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
Center for Intractable Diseases, Saitama Medical University Hospital, Saitama, Japan.

Yukiko Yatsuka (Y)

Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan.

Yoshihito Kishita (Y)

Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Department of Life Science, Faculty of Science and Engineering, Kindai University, Osaka, Japan.

Masakazu Kohda (M)

Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan.

Akira Namba (A)

Department of Clinical Genomics, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
Center for Intractable Diseases, Saitama Medical University Hospital, Saitama, Japan.
Department of Obstetrics and Gynecology, Saitama Medical University Hospital, Saitama, Japan.

Yoshimasa Kamei (Y)

Department of Obstetrics and Gynecology, Saitama Medical University Hospital, Saitama, Japan.

Yasushi Okazaki (Y)

Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan.

Shinji Kosugi (S)

Department of Medical Genetics/Medical Ethics, Kyoto University School of Public Health, Kyoto, Japan.

Akira Ohtake (A)

Department of Pediatrics, Faculty of Medicine, Saitama Medical University, Saitama, Japan. akira_oh@saitama-med.ac.jp.
Department of Clinical Genomics, Faculty of Medicine, Saitama Medical University, Saitama, Japan. akira_oh@saitama-med.ac.jp.
Center for Intractable Diseases, Saitama Medical University Hospital, Saitama, Japan. akira_oh@saitama-med.ac.jp.

Kei Murayama (K)

Center for Medical Genetics, Chiba Children's Hospital, Chiba, Japan. kmuraya@mri.biglobe.ne.jp.
Department of Metabolism, Chiba Children's Hospital, 579-1 Heta-cho, Midori-ku, Chiba, 266-0007, Japan. kmuraya@mri.biglobe.ne.jp.
Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan. kmuraya@mri.biglobe.ne.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH